Cargando…
Construction and characterisation of a recombinant fowlpox virus that expresses the human papilloma virus L1 protein
BACKGROUND: Human papilloma virus (HPV)-16 is the most prevalent high-risk mucosal genotype. Virus-like-particle (VLP)-based immunogens developed recently have proven to be successful as prophylactic HPV vaccines, but are still too expensive for developing countries. Although vaccinia viruses expres...
Autores principales: | Zanotto, Carlo, Pozzi, Eleana, Pacchioni, Sole, Bissa, Massimiliano, De Giuli Morghen, Carlo, Radaelli, Antonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3231814/ https://www.ncbi.nlm.nih.gov/pubmed/22053827 http://dx.doi.org/10.1186/1479-5876-9-190 |
Ejemplares similares
-
Fowlpox virus recombinants expressing HPV-16 E6 and E7 oncogenes for the therapy of cervical carcinoma elicit humoral and cell-mediated responses in rabbits
por: Radaelli, Antonia, et al.
Publicado: (2010) -
L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines
por: Pacchioni, Sole Maria, et al.
Publicado: (2013) -
Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain
por: Bissa, Massimiliano, et al.
Publicado: (2013) -
Protection of mice against the highly pathogenic VV(IHD-J) by DNA and fowlpox recombinant vaccines, administered by electroporation and intranasal routes, correlates with serum neutralizing activity
por: Bissa, Massimiliano, et al.
Publicado: (2016) -
A prime/boost strategy using DNA/fowlpox recombinants expressing the genetically attenuated E6 protein as a putative vaccine against HPV-16-associated cancers
por: Bissa, Massimiliano, et al.
Publicado: (2015)